The American Society of Clinical Oncology (ASCO) annual meeting in Chicago this week marked a historic milestone as one of... Read more
Tag: #Global Trends
Ministry of Health issues Circular No. 18/2026/TT-BYT to tighten controlled drug management and advance digital records
The Ministry of Health has officially promulgated Circular No. 18/2026/TT-BYT, detailing select articles of the Law on Pharmacy and Decree... Read more
Australia triggers urgent recall for two Nature’s Own supplements and Allen’s gummy candy over foreign matter risks
Regulatory bodies in Australia have issued concurrent urgent safety recall notices targeting two widely distributed dietary supplement variants under the... Read more
Australia issues urgent recall for two Nature’s Own supplements and Allen’s gummy candy over foreign matter contamination
Regulatory authorities in Australia have issued concurrent urgent safety recall notices targeting two widely distributed dietary supplement variants under the... Read more
Travere licenses Everest Medicines’ kidney drug in a strategic alliance valued up to $1.14 billion
Biopharmaceutical developer Travere Therapeutics has entered into a definitive global licensing covenant with biotechnology firm Everest Medicines to collaboratively develop... Read more
US announces re-engagement with Gavi vaccine alliance amid worsening African Ebola outbreak
WASHINGTON/LONDON (Reuters) — U.S. Secretary of State Marco Rubio has formally announced that the United States will resume its operational... Read more
FDA accepts Roche’s NDA for early-stage breast cancer therapy giredestrant under Priority Review
The United States Food and Drug Administration (FDA) has formally accepted Roche's New Drug Application (NDA) and granted Priority Review... Read more
Merck trims New Jersey headcount by 88 as part of a $3 billion global restructuring plan
U.S. pharmaceutical titan Merck & Co. has initiated the next phase of its ongoing corporate reorganization, cutting 88 positions at... Read more
Western pharma giants’ billion-dollar investments in China trigger intense regulatory backlash in the US
International financial and medical registries have logged a major wave of capital reallocation as dominant U.S. and European pharmaceutical conglomerates... Read more








